Interestingly, inhibition of c-Met conferred radiosensitization in glioma, glioblastoma, NSCLC, prostate cancer cells, and their xenografts through cell cycle arrest, inhibition of DNA repair, or induction of apoptosis (31–33). Here, MET is linked to glioblastoma.